Waters Other Long-Term Assets 2010-2025 | WAT
Waters other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Waters other long-term assets for the quarter ending March 31, 2025 were $0.270B, a 11.35% increase year-over-year.
- Waters other long-term assets for 2024 were $0.296B, a 37.08% increase from 2023.
- Waters other long-term assets for 2023 were $0.216B, a 12.87% increase from 2022.
- Waters other long-term assets for 2022 were $0.191B, a 24.84% increase from 2021.
| Waters Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $296 |
| 2023 | $216 |
| 2022 | $191 |
| 2021 | $153 |
| 2020 | $149 |
| 2019 | $138 |
| 2018 | $119 |
| 2017 | $117 |
| 2016 | $130 |
| 2015 | $147 |
| 2014 | $151 |
| 2013 | $112 |
| 2012 | $100 |
| 2011 | $55 |
| 2010 | $53 |
| 2009 | $49 |
| Waters Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $270 |
| 2024-12-31 | $296 |
| 2024-09-30 | $246 |
| 2024-06-30 | $234 |
| 2024-03-31 | $242 |
| 2023-12-31 | $216 |
| 2023-09-30 | $222 |
| 2023-06-30 | $196 |
| 2023-03-31 | $192 |
| 2022-12-31 | $191 |
| 2022-09-30 | $227 |
| 2022-06-30 | $191 |
| 2022-03-31 | $150 |
| 2021-12-31 | $153 |
| 2021-09-30 | $160 |
| 2021-06-30 | $162 |
| 2021-03-31 | $163 |
| 2020-12-31 | $149 |
| 2020-09-30 | $145 |
| 2020-06-30 | $155 |
| 2020-03-31 | $141 |
| 2019-12-31 | $138 |
| 2019-09-30 | $159 |
| 2019-06-30 | $143 |
| 2019-03-31 | $121 |
| 2018-12-31 | $119 |
| 2018-09-30 | $123 |
| 2018-06-30 | $122 |
| 2018-03-31 | $107 |
| 2017-12-31 | $117 |
| 2017-09-30 | $158 |
| 2017-06-30 | $134 |
| 2017-03-31 | $133 |
| 2016-12-31 | $130 |
| 2016-09-30 | $135 |
| 2016-06-30 | $142 |
| 2016-03-31 | $141 |
| 2015-12-31 | $147 |
| 2015-09-30 | $127 |
| 2015-06-30 | $120 |
| 2015-03-31 | $117 |
| 2014-12-31 | $151 |
| 2014-09-30 | $129 |
| 2014-06-30 | $127 |
| 2014-03-31 | $120 |
| 2013-12-31 | $112 |
| 2013-09-30 | $111 |
| 2013-06-30 | $111 |
| 2013-03-31 | $107 |
| 2012-12-31 | $100 |
| 2012-09-30 | $69 |
| 2012-06-30 | $61 |
| 2012-03-31 | $63 |
| 2011-12-31 | $55 |
| 2011-09-30 | $61 |
| 2011-06-30 | $64 |
| 2011-03-31 | $62 |
| 2010-12-31 | $53 |
| 2010-09-30 | $77 |
| 2010-06-30 | $52 |
| 2010-03-31 | $52 |
| 2009-12-31 | $49 |
| 2009-09-30 | $80 |
| 2009-06-30 | $71 |
| 2009-03-31 | $66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.195B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |